The Effects of Rimonabant, on Weight and Metabolic Risk Factors

Clinical trial NCT00547118 · TERMINATED

Trial details

NCT number: NCT00547118
Sponsor: University of Maryland, Baltimore
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Obesity Hypertension Smoking

Start date: 2007-11-01
Primary completion: 2009-03-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.